Reversion of disease manifestations after HCV eradication Adriaan J. van der Meer, Marina Berenguer  Journal of Hepatology  Volume 65, Issue 1, Pages S95-S108 (October 2016) DOI: 10.1016/j.jhep.2016.07.039 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Simplified scheme for indication of antiviral therapy and follow-up of patients with chronic HCV infection. ∗Consider drug-specific and/or psychosocial contraindications for antiviral treatment. #This concerns a suggested approach. There is no data for any hard clinical recommendations. $Take the center-specific waiting time for liver transplantation into account. HCC, hepatocellular carcinoma; HCV, hepatitis C virus; LT, liver transplantation; MELD, Model for End-Stage Liver Disease; SVR, sustained virological response. Journal of Hepatology 2016 65, S95-S108DOI: (10.1016/j.jhep.2016.07.039) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions